Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia
Alzheimer's & Dementia · 2026-04 · 22 (4)
DOI: 10.1002/alz.71390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.04.2026. Verfasst von Malgorzata Gorniak-Walas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Microglia, LDL-Receptor Related Proteins, Alzheimer Disease. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Foundation, Novo Nordisk Fonden.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The rs11218343 is a non‐coding variant of genome‐wide significance for sporadic Alzheimer's disease (AD) with one of the most protective effects known to date. It localizes to SORL1 , encoding the AD risk factor Sortilin‐related receptor with A type repeats (SORLA). Still, the functional significance of rs11218343 for AD‐related processes remains unclear. METHODS We used induced pluripotent stem cell (iPSC) lines from donors, or genome‐engineered to carry major and minor rs11218343 alleles, to study the impact of rs11218343 on cellular activities. RESULTS We show that rs11218343 is uniquely linked to functional expression of SORLA in microglia, with increased expression in the protective allele correlating with reduced pro‐inflammatory responses. These anti‐inflammatory effects are seen in donor lines but not in single nucleotide polymorphism (SNP) ‐engineered isogenic lines, arguing that this polymorphism alone is insufficient but acting context‐dependent. DISCUSSION Our data infer genetically defined expression of SORL1 in microglia as a determinant of protection from pro‐inflammatory stimulation, a function likely encoded by a haplotype linked to rs11218343.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Technology Platform for Pluripotent Stem Cells, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- Molecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Förderung
- Novo Nordisk Foundation
- Novo Nordisk Fonden
Zitieren
APA
Gorniak-Walas, M., Telugu, N. S., Rudolph, I. M., Diecke, S., & Willnow, T. E. (2026). Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71390
Vancouver
Gorniak-Walas M, Telugu NS, Rudolph IM, Diecke S, Willnow TE. Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71390
BibTeX
@article{GorniakWalas2026,
author = {Gorniak-Walas, Malgorzata and Telugu, Narasimha S and Rudolph, Ina-Maria and Diecke, Sebastian and Willnow, Thomas E},
title = {Alzheimer's disease risk single nucleotide polymorphism rs11218343 is linked to functional expression of SORL1 in microglia},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {4},
doi = {10.1002/alz.71390}
}
EUVIMED